Full name
ZARAPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.90.Z - Non-specialized wholesale trade
10.89.Z - Production of other food products, not elsewhere classified
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
47.29.Z - Retail trade
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
2022 | 2023 | 2024 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | 0 |
EBITDA | -397,8 | |||
Short time liabilities | -23,6 | |||
Equity capital | -70,6 | |||
Operating profit (EBIT) | -397,8 | |||
Assets | -35,9 | |||
Net profit (loss) | 0 | 0 | 0 | 0 |
Cash | -16,5 | |||
Net income from sale | -15,2 | |||
Liabilities and provisions for liabilities | -9,8 | |||
Working assets | -35,9 | |||
Depreciation | 0 | |||
% | % | % | p.p. | |
Profitability of capital | -240,2 | |||
Equity capital to total assets | -23,2 | |||
Gross profit margin | -50,1 | |||
EBITDA Margin | -57,5 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | -12 | |||
Current financial liquidity indicator | -0,7 | |||
Net dept to EBITDA | 3,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane